Mechanistically, METTL3 overexpression in advanced RCC is driven by HIF-1α in hypoxia, facilitating m6A-dependent PLOD2 upregulation to drive tumor proliferation and metastasis (Chen et al., 2024a). Here, METTL3 is linked to neoplasm.